CVS Health (NYSE:CVS) Shares Down 11.2% – What’s Next?

CVS Health Corporation (NYSE:CVS)’s stock price dropped 11.2% during trading on Wednesday. The stock traded as low as $77.33 and last traded at $81.1960. Approximately 6,524,275 shares changed hands during mid-day trading, a decline of 21% from the average daily volume of 8,306,744 shares. The stock had previously closed at $91.41.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates, with revenue up 5.4% year over year. Management raised its 2026 adjusted EPS outlook to at least $8.29 and projected operating cash flow of at least $15.5 billion. CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
• Neutral Sentiment: UBS kept a Buy rating while lowering its price target to $107, indicating continued potential upside in its view but also a more cautious valuation. Tickerreport.com report on UBS price target
• Negative Sentiment: The planned separation by 2028 caught investors off guard. CVS has yet to provide key details on the new companies’ standalone finances, separation costs, debt allocation, or how its dividend would be handled. This lack of clarity appears to have outweighed the earnings beat, and shares dropped sharply after the announcement. CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
• Negative Sentiment: The separation would split retail pharmacies and related services from the health-services business, including Aetna and Caremark. Investors may also be concerned about regulatory pressures and relatively modest expected 2027 growth, while the long timeline leaves room for further changes. CVS to split into two companies

Analysts Set New Price Targets

A number of research analysts have commented on the company. JPMorgan Chase & Co. upped their price objective on CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Royal Bank Of Canada lifted their target price on CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. BMO Capital Markets set a $112.00 target price on shares of CVS Health in a research report on Wednesday, September 9th. Wells Fargo & Company upped their price target on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Finally, UBS Group lowered their price target on shares of CVS Health from $118.00 to $107.00 and set a “buy” rating on the stock in a research report on Thursday. Twenty-two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $108.25.

CVS Health Price Performance

The stock has a market cap of $107.05 billion, a P/E ratio of 9.75, a price-to-earnings-growth ratio of 0.73 and a beta of 0.58. The business has a 50-day simple moving average of $90.56 and a 200 day simple moving average of $88.87. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.71.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.65 by $0.44. The firm had revenue of $108.40 billion during the quarter, compared to the consensus estimate of $104.72 billion. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The business’s revenue was up 5.4% compared to the same quarter last year. During the same period last year, the business posted $1.60 EPS. On average, analysts forecast that CVS Health Corporation will post 8.20 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were issued a $0.6650 dividend. The ex-dividend date was Thursday, October 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. CVS Health’s dividend payout ratio is currently 30.97%.

Hedge Funds Weigh In On CVS Health

Several institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new position in CVS Health during the second quarter valued at $12,747,462,000. State Street Corp raised its stake in shares of CVS Health by 26.3% in the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after buying an additional 15,604,883 shares during the period. Bank of America Corp DE raised its stake in shares of CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after buying an additional 13,836,701 shares during the period. Pzena Investment Management LLC purchased a new position in shares of CVS Health during the 2nd quarter valued at $1,217,558,000. Finally, Wellington Management Group LLP grew its stake in shares of CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after acquiring an additional 11,233,381 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.